These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9822896

  • 1. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells.
    Takano M, Hasegawa R, Fukuda T, Yumoto R, Nagai J, Murakami T.
    Eur J Pharmacol; 1998 Oct 09; 358(3):289-94. PubMed ID: 9822896
    [Abstract] [Full Text] [Related]

  • 2. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
    Raeissi SD, Hidalgo IJ, Segura-Aguilar J, Artursson P.
    Pharm Res; 1999 May 09; 16(5):625-32. PubMed ID: 10350002
    [Abstract] [Full Text] [Related]

  • 3. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R, Murakami T, Nakamoto Y, Hasegawa R, Nagai J, Takano M.
    J Pharmacol Exp Ther; 1999 Apr 09; 289(1):149-55. PubMed ID: 10086998
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M.
    Drug Metab Dispos; 2001 Feb 09; 29(2):145-51. PubMed ID: 11159804
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM, Velez RL, von Moltke LL, Greenblatt DJ.
    Clin Pharmacol Ther; 1999 Nov 09; 66(5):461-71. PubMed ID: 10579473
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects.
    Mueck W, Kubitza D, Becka M.
    Br J Clin Pharmacol; 2013 Sep 09; 76(3):455-66. PubMed ID: 23305158
    [Abstract] [Full Text] [Related]

  • 10. Dose-dependent intestinal and hepatic first-pass metabolism of midazolam, a cytochrome P450 3A substrate with differently modulated enzyme activity in rats.
    Higashikawa F, Murakami T, Kaneda T, Kato A, Takano M.
    J Pharm Pharmacol; 1999 Jan 09; 51(1):67-72. PubMed ID: 10197420
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio.
    Kinirons MT, Krivoruk Y, Wilkinson GR, Wood AJ.
    Br J Clin Pharmacol; 1999 Feb 09; 47(2):223-5. PubMed ID: 10190659
    [No Abstract] [Full Text] [Related]

  • 16. In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats.
    Kageyama M, Namiki H, Fukushima H, Ito Y, Shibata N, Takada K.
    Biol Pharm Bull; 2005 Feb 09; 28(2):316-22. PubMed ID: 15684491
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4.
    Achira M, Suzuki H, Ito K, Sugiyama Y.
    AAPS PharmSci; 1999 Feb 09; 1(4):E18. PubMed ID: 11741214
    [Abstract] [Full Text] [Related]

  • 19. Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis.
    Ragueneau-Majlessi I, Boulenc X, Rauch C, Hachad H, Levy RH.
    Curr Drug Metab; 2007 Dec 09; 8(8):810-4. PubMed ID: 18220561
    [Abstract] [Full Text] [Related]

  • 20. Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole.
    Jamis-Dow CA, Pearl ML, Watkins PB, Blake DS, Klecker RW, Collins JM.
    Am J Clin Oncol; 1997 Dec 09; 20(6):592-9. PubMed ID: 9391548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.